Company Filing History:
6 out of 2,100 
4 out of 56 
2 out of 289 
Years Active: 2008-2025
Title: Mark J Rieder: Innovator in Infectious Disease Diagnosis
Introduction
Mark J Rieder is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of infectious disease diagnosis. With a total of 10 patents to his name, Rieder has developed innovative methods that enhance the understanding and detection of infectious agents.
Latest Patents
Rieder's latest patents include groundbreaking methods for diagnosing infectious diseases and determining HLA status using immune repertoire sequencing. These methods predict a subject's infection status by utilizing high-throughput T cell receptor sequencing to match the subject's TCR repertoire with a known set of disease-associated T cell receptor sequences. This innovative approach allows for the prediction of several infectious agents from a single sample. Additionally, Rieder has developed methods using randomer-containing synthetic molecules to correct amplification bias and quantify adaptive immune cells in a sample. These synthetic templates incorporate random oligonucleotide sequences, further advancing the field of immune cell analysis.
Career Highlights
Throughout his career, Rieder has worked with esteemed institutions such as the University of Washington and Adaptive Biotechnologies Corporation. His work has significantly impacted the understanding of immune responses and the development of diagnostic tools.
Collaborations
Rieder has collaborated with notable colleagues, including Allan Rettie and Harlan Saul Robins, contributing to the advancement of research in immunology and infectious diseases.
Conclusion
Mark J Rieder's innovative work in the field of infectious disease diagnosis showcases his dedication to advancing medical science. His patents reflect a commitment to improving diagnostic methods and understanding immune responses, making a lasting impact in the field.